世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

持続可能な医薬品包装市場：原材料（プラスチック、紙・板紙、ガラス、金属）、製品タイプ、プロセス（再生可能、再利用可能、生分解性）、包装タイプ（一次包装）、地域別 - 2027年までの世界予測


Sustainable Pharmaceutical Packaging Market by Raw Material (Plastics, Paper & paperboard, Glass, Metal), Product Type, Process (Recyclable, Reusable, and Biodegradable), Packaging Type(Primary Packaging), and Region - Global Forecast to 2027

持続可能な医薬品包装の世界市場規模は、2022年の716億米ドルから2027年には1463億米ドルへと、2022年から2027年にかけて15.4%の年率で成長すると予測されます。 持続可能な医薬品包装は、医薬品の完全性を保護... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 図表数 言語
MarketsandMarkets
マーケッツアンドマーケッツ 		2023年2月17日 US$4,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		278 272 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

持続可能な医薬品包装の世界市場規模は、2022年の716億米ドルから2027年には1463億米ドルへと、2022年から2027年にかけて15.4%の年率で成長すると予測されます。
持続可能な医薬品包装は、医薬品の完全性を保護し、包装材料が環境に与える影響を軽減することを目的としているため、ヘルスケア産業において重要な側面となっています。廃棄物の削減と天然資源の保護にますます注目が集まる中、製薬会社は機能的で環境に優しい包装を作るための新しい革新的な方法を模索しています。これには、リサイクル可能な材料の使用、リサイクルしやすい設計、包装の削減戦略の実施などが含まれます。

"医薬品包装市場の他の原材料の中で、ガラスが第3位のシェアを占めている"
ガラスは、優れた透明性と化学的不活性を持つ非晶質・結晶性の材料です。主に医薬品の一次包装に使用されています。バイアル、アンプル、ボトル、容器、注射器など、さまざまな種類の一次包装がガラスで作られています。ガラスは、無限にリサイクル・再利用が可能な永久素材であり、廃棄物の削減や天然資源の節約につながります。つまり、ガラスは本来の特性を損なうことなく、何度でもリサイクルできる可能性を持っているのです。恒久的な素材は、真の意味での循環型マテリアルループを維持するのに最適です。化学結合の強さにより、永久磁石はリサイクルの過程でダメージを受けることがなく、適切に回収、処理、再溶解される限り、リサイクルループにとどまることができます。

"予測期間中、繊維パルプモールドパッケージでは二次包装が二番目に大きな包装タイプになる"

持続可能な医薬品包装における二次包装とは、実際の医薬品が入った一次包装を包む外装のことを指します。一次包装を保護し、用量、有効期限、製造者などの製品に関する情報を提供します。二次包装は、小売準備包装（RRP）、棚準備包装（SRP）、カウンタートップ・ディスプレイ・ユニット（CDU）としても知られています。この包装により、小売業者は製品の陳列や取り扱いを容易にすることができます。環境負荷の低減を目指す製薬業界では、二次包装に持続可能な素材を使用することがますます重要になってきています。

"予測期間中、リサイクル可能なプロセスが持続可能な医薬品パッケージの最大シェアを占めました。"

持続可能な医薬品パッケージング業界において、企業や消費者がパッケージング材料の影響を意識するようになり、リサイクル可能なプラスチックの使用はますます重要性を増しています。PETやHDPEなどのリサイクル可能なプラスチックを使用することで、環境に優しいだけでなく、費用対効果が高く、医薬品の保管や輸送に安全なパッケージを作ることができます。医薬品包装にリサイクル可能なプラスチックを使用する主な利点の1つは、埋立地に廃棄される量を減らすことができることです。これらの材料は簡単に回収、選別、リサイクルすることができ、天然資源の保護と業界の二酸化炭素排出量の削減に貢献します。さらに、リサイクル可能なプラスチックは軽量であることが多いため、輸送や保管にかかる費用対効果が高くなります。また、湿気や光などの環境要因から製品を守るバリア性にも優れています。




"欧州は、持続可能な医薬品パッケージの2番目に大きな市場になること"
この地域における医薬品包装の高い需要は、医薬品の研究、生産、流通が増加していることに起因しています。医療用バイオ医薬品の分野での著しい進歩が、この地域の市場をさらに押し上げています。現在、この地域の消費者、メーカー、小売業者、支援団体、政府は環境に配慮した包装を推奨しており、環境意識の高い消費者が多いドイツ、フランス、イギリスなどの国々で持続可能な医薬品包装産業の安定した成長に寄与しています。これらの要因が、欧州地域における持続可能な医薬品包装の需要を促進すると予想されます。

本調査は、世界中の様々な業界専門家に行った一次調査によって検証されています。これらの一次情報源は、企業別、呼称別、地域別の3つのカテゴリーに分類されています。
- 部門別 - 営業/輸出/マーケティング - 53.5%, 生産 - 23.3%, CXOs - 23.3
- 役職別：マネージャー60.5％、CXO23.3％、エグゼクティブ16.3
- 地域別：北米33％、欧州27％、アジア太平洋25％、南米5％、中近東・アフリカ10
持続可能な医薬品包装市場の主要企業は、Schott AG（ドイツ）、Amcor PLC（スイス）、AptarGroup,Inc（米国）、West Pharmaceutical Services, Inc（米国）、Berry Global（米国）、Gerresheimer AG（ドイツ）、Catalent, Inc（米国）、WestRock（米国）です。本調査では、持続可能な医薬品包装市場におけるこれらの主要企業の詳細な競合分析、会社概要、主要な市場戦略などを掲載しています。

調査対象
本レポートでは、持続可能な医薬品包装市場の詳細なセグメント分けと、2027年までの市場規模を予測しています。市場は、原材料、製品タイプ、包装タイプ、プロセス、地域に基づいてセグメント化されています。また、企業プロフィールや、市場における地位を強化するために主要企業が採用した競争戦略に関する詳細な情報を提供しています。また、持続可能な医薬品包装市場の推進要因と抑制要因、これらの産業にわたる機会と課題に関する洞察も提供しています。また、市場のトップメーカーのプロフィールも掲載しています。
本レポートを購入する理由
洞察の観点から、この調査レポートは様々なレベルの分析に焦点を当てています - 業界分析（業界動向）、トッププレイヤーの市場ランキング、企業プロフィール、これらは共に競争環境に関する基本的な見解を構成し議論します - 持続可能な医薬品包装市場の新興および高成長セグメント、高成長地域、市場促進、抑制、機会、および挑戦

ページTOPに戻る


目次

1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.3 STUDY SCOPE 35
1.3.1 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SEGMENTATION 35
1.3.2 REGIONAL SCOPE 35
1.4 YEARS CONSIDERED 36
1.5 CURRENCY CONSIDERED 36
1.6 UNIT CONSIDERED 36
1.7 STAKEHOLDERS 36
1.8 INCLUSIONS AND EXCLUSIONS 37
TABLE 1 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: INCLUSIONS AND EXCLUSIONS 37
1.9 SUMMARY OF CHANGES 37
1.10 LIMITATIONS 38
2 RESEARCH METHODOLOGY 39
2.1 RESEARCH DATA 39
FIGURE 1 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: RESEARCH DESIGN 39
2.1.1 SECONDARY DATA 40
2.1.1.1 Key data from secondary sources 40
2.1.2 PRIMARY DATA 40
2.1.2.1 Key data from primary sources 41
2.1.2.2 Key primary insights 42
FIGURE 2 LIST OF STAKEHOLDERS AND BREAKDOWN OF PRIMARY INTERVIEWS 42
2.2 MARKET SIZE ESTIMATION 43
FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 43
FIGURE 4 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 43
FIGURE 5 MARKET SIZE ESTIMATION: SUPPLY SIDE 44
2.3 DATA TRIANGULATION 45
FIGURE 6 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: DATA TRIANGULATION 45
2.4 RESEARCH ASSUMPTIONS 46
2.5 RESEARCH LIMITATIONS 46
2.6 GROWTH FORECAST 46
3 EXECUTIVE SUMMARY 47
FIGURE 7 PLASTICS TO HOLD LARGEST SHARE IN SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET 47
FIGURE 8 PRIMARY PACKAGING TO BE FASTER-GROWING SEGMENT OF SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET 48
FIGURE 9 BIODEGRADABLE SEGMENT TO GROW AT HIGHEST CAGR FROM 2022 TO 2027 48
FIGURE 10 ASIA PACIFIC TO BE FASTEST-GROWING PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD 49
4 PREMIUM INSIGHTS 50
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET 50
FIGURE 11 EMERGING ECONOMIES TO OFFER ATTRACTIVE OPPORTUNITIES IN SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET 50
4.2 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL 50
FIGURE 12 PLASTICS SEGMENT TO REGISTER HIGHEST CAGR FROM 2022 TO 2027 50
4.3 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION AND RAW MATERIAL, 2021 51
FIGURE 13 NORTH AMERICA AND PLASTICS SEGMENT ACCOUNTED FOR LARGEST SHARES 51
4.4 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY KEY COUNTRIES 52
FIGURE 14 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET IN INDIA TO WITNESS HIGHEST CAGR 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 54
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET 54
5.2.1 DRIVERS 54
5.2.1.1 Government initiatives for sustainable packaging 54
5.2.1.2 Consumer preference toward recyclable and eco-friendly materials 55
5.2.1.3 Downsizing of packaging 56
5.2.1.4 Breakthrough in new technologies and innovations 56
5.2.1.5 High growth in generics and biopharmaceuticals markets 57
5.2.2 RESTRAINTS 57
5.2.2.1 Poor infrastructure facilities for recycling 57
5.2.2.2 Lack of awareness of sustainability 57
5.2.2.3 High packaging costs 58
5.2.3 OPPORTUNITIES 59
5.2.3.1 Growing demand for primary pharmaceutical packaging 59
5.2.4 CHALLENGES 59
5.2.4.1 Volatile raw material prices 59
5.3 VALUE CHAIN ANALYSIS 60
FIGURE 16 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: VALUE CHAIN ANALYSIS 60
5.3.1 RAW MATERIAL SUPPLIERS 60
5.3.2 R&D OF PRODUCTS 60
5.3.3 MANUFACTURERS 61
5.3.4 DISTRIBUTORS 61
5.3.5 END USERS 61
5.3.6 POST-DISPOSAL PROCESS 62
TABLE 2 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKETING: VALUE CHAIN STAKEHOLDERS 63
5.4 PORTER'S FIVE FORCES ANALYSIS 64
FIGURE 17 PORTER'S FIVE FORCES ANALYSIS OF SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET 64
5.4.1 THREAT OF NEW ENTRANTS 64
5.4.2 THREAT OF SUBSTITUTES 65
5.4.3 BARGAINING POWER OF BUYERS 65
5.4.4 BARGAINING POWER OF SUPPLIERS 66
5.4.5 INTENSITY OF COMPETITIVE RIVALRY 66
TABLE 3 IMPACT OF PORTER'S FIVE FORCES ON SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET 66
5.5 REGULATORY LANDSCAPE 67
5.5.1 REGULATIONS 67
5.5.1.1 Europe 67
5.5.1.2 US 67
5.5.1.3 Others 68
5.6 TECHNOLOGY ANALYSIS 68
5.6.1 AUTOMATED RECYCLING 68
5.6.2 EMERGENCE OF TECHNOLOGICALLY ADVANCED RAW MATERIALS 68
5.6.3 NANOTECHNOLOGY 69
5.6.4 PACKAGING FOR BIOLOGICS 69
5.6.5 SMART PACKAGING 69
5.6.6 ANTI-COUNTERFEIT PACKAGING 70
5.6.7 OTHER SMART TRENDS AND TECHNOLOGIES 70
5.7 PRICING ANALYSIS 71
5.7.1 AVERAGE SELLING PRICE, BY REGION 71
FIGURE 18 AVERAGE SELLING PRICE, BY REGION (USD/KG) 71
5.7.2 AVERAGE SELLING PRICE, BY RAW MATERIAL 71
TABLE 4 AVERAGE SELLING PRICE, BY RAW MATERIAL (USD/KG) 71
5.7.3 AVERAGE SELLING PRICE, BY COMPANY 72
TABLE 5 AVERAGE SELLING PRICE, BY COMPANY (USD/KG) 72
5.8 ECOSYSTEM MAPPING 72
FIGURE 19 PHARMACEUTICAL PACKAGING MARKET: ECOSYSTEM MAPPING 72
5.9 IMPACT OF COVID-19 ON PHARMACEUTICAL PACKAGING MARKET 73
5.9.1 IMPACT ON HEALTHCARE INDUSTRY 73
5.10 IMPACT OF RECESSION ON PHARMACEUTICAL PACKAGING MARKET 74
5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 75
FIGURE 20 SMART PACKAGING, IOT, AND NANOTECHNOLOGY TO DRIVE MARKET 75
5.12 PATENT ANALYSIS 75
5.12.1 INTRODUCTION 75
5.12.2 METHODOLOGY 75
5.12.3 DOCUMENT TYPE 76
FIGURE 21 GRANTED PATENTS, LIMITED PATENTS, AND PATENT APPLICATIONS 76
5.12.4 PUBLICATION TRENDS DURING 2011–2021 76
FIGURE 22 NUMBER OF PATENTS DURING 2011–2021 76
5.12.5 INSIGHTS 77
5.12.6 JURISDICTION ANALYSIS 77
FIGURE 23 TOP JURISDICTIONS 77
5.12.7 TOP PATENT APPLICANTS 77
FIGURE 24 TOP 10 PATENT APPLICANTS 78
TABLE 6 LIST OF PATENTS BY SANOFI AVENTIS DEUTSCHLAND 78
TABLE 7 LIST OF PATENTS BY SCHOTT AG 79
TABLE 8 LIST OF PATENTS BY TERUMO CORP 79
TABLE 9 LIST OF PATENTS BY BECTON, DICKINSON AND COMPANY 80
TABLE 10 TOP 10 PATENT OWNERS (US) IN LAST 10 YEARS 81
5.13 TRADE ANALYSIS 81
5.14 OPERATIONAL DATA 82
5.15 KEY CONFERENCES AND EVENTS IN 2022–2023 83
TABLE 11 KEY CONFERENCES AND EVENTS IN 2022–2023 83
5.16 CASE STUDY ANALYSIS 84
5.16.1 OPTHALMIC SQUEEZE DISPENSER BY APTAR PHARMA TO CONTRIBUTE TO OVERALL ESG COMMITMENTS 84
5.16.2 MOISTURE BARRIER TECHNOLOGY FOR BETTER DRUG DELIVERY 84
5.16.3 CUSTOM TECHNOLOGY FOR BETTER BREATHING 85
6 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL 86
6.1 INTRODUCTION 87
FIGURE 25 PLASTICS TO DOMINATE SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET 87
TABLE 12 BASIC PACKAGING RAW MATERIALS USED IN PHARMACEUTICAL PACKAGING 87
TABLE 13 RAW MATERIAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 88
TABLE 14 RAW MATERIAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 89
TABLE 15 RAW MATERIAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (KILOTON) 89
TABLE 16 RAW MATERIAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (KILOTON) 89
TABLE 17 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (USD MILLION) 90
TABLE 18 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (USD MILLION) 90
TABLE 19 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (KILOTON) 90
TABLE 20 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (KILOTON) 91
6.2 PLASTICS 91
6.2.1 COST-EFFECTIVENESS AND EXCELLENT BARRIER PROPERTIES OF PLASTICS TO DRIVE MARKET 91
TABLE 21 PLASTICS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 92
TABLE 22 PLASTICS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 92
TABLE 23 PLASTICS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (KILOTON) 92
TABLE 24 PLASTICS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (KILOTON) 93
6.2.2 HIGH-DENSITY POLYETHYLENE (HDPE) 93
6.2.3 POLYPROPYLENE (PP) 93
6.2.4 LOW-DENSITY POLYETHYLENE (LDPE) 94
6.2.5 POLYVINYL CHLORIDE (PVC) 94
6.2.6 POLYETHYLENE TEREPHTHALATE (PET) 94
6.2.7 BIO-BASED PLASTICS (BBP) 94
6.2.8 BIODEGRADABLE PLASTICS 95
6.3 PAPER & PAPERBOARD 95
6.3.1 INNOVATIONS IN SECONDARY PACKAGING TO BOOST MARKET 95
TABLE 25 PAPER & PAPERBOARD: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 96
TABLE 26 PAPER & PAPERBOARD: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 96
TABLE 27 PAPER & PAPERBOARD: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (KILOTON) 96
TABLE 28 PAPER & PAPERBOARD: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (KILOTON) 97
6.4 GLASS 97
6.4.1 EXCELLENT CHEMICAL RESISTANCE AND RECYCLABILITY OF GLASS TO PROPEL MARKET 97
TABLE 29 GLASS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 98
TABLE 30 GLASS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 98
TABLE 31 GLASS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (KILOTON) 98
TABLE 32 GLASS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (KILOTON) 99
TABLE 33 TYPES OF GLASS USED IN PACKAGING 100
6.5 METAL 100
6.5.1 INCREASING USE OF ALUMINUM FOR BLISTER PACKAGING TO DRIVE MARKET 100
TABLE 34 METAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 101
TABLE 35 METAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 101
TABLE 36 METAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (KILOTON) 102
TABLE 37 METAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (KILOTON) 102
6.6 OTHER RAW MATERIALS 103
TABLE 38 OTHER RAW MATERIALS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 104
TABLE 39 OTHER RAW MATERIALS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 104
TABLE 40 OTHER RAW MATERIALS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (KILOTON) 104
TABLE 41 OTHER RAW MATERIALS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (KILOTON) 105
7 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PRODUCT TYPE 106
7.1 INTRODUCTION 106
7.2 PLASTIC BOTTLES 106
7.2.1 EASY OPERABILITY AND SHATTER RESISTANCE OF PLASTIC BOTTLES TO SUPPORT MARKET 106
7.2.2 STANDARD PLASTIC BOTTLES 107
7.2.3 PLASTIC DISPENSING BOTTLES 107
7.2.4 PLASTIC JARS 107
7.3 LABELS & ACCESSORIES 107
7.3.1 PATIENT-DRUG COMMUNICATION COMPLIANCE TO DRIVE MARKET 107
7.3.2 SELF-ADHESIVE LABELS 108
7.3.3 DIE-CUT LABELS 108
7.3.4 TAMPER-PROOF LABELS 108
7.3.5 HOLOGRAPHIC STRIP LABELS 108
7.4 CAPS & CLOSURES 109
7.4.1 PREFERENCE FOR POLYPROPYLENE AND POLYETHYLENE-BASED CAPS & CLOSURES TO FAVOR MARKET GROWTH 109
7.5 MEDICAL SPECIALTY BAGS 109
7.5.1 WIDE USE OF LLDPE AND PE TO CONTRIBUTE TO MARKET GROWTH 109
7.6 PREFILLED SYRINGES 110
7.6.1 HIGH DEMAND IN DEVELOPED AND EMERGING ECONOMIES TO DRIVE MARKET 110
7.7 TEMPERATURE-CONTROLLED PACKAGING 110
7.7.1 INCREASING PRODUCTION OF SPECIALIZED DRUGS TO INFLUENCE MARKET GROWTH POSITIVELY 110
7.8 POUCHES & STRIP PACKS 111
7.8.1 GROWING DEMAND FOR STANDUP POUCHES TO DRIVE MARKET 111
7.9 AMPOULES 111
7.9.1 HIGH DEMAND FROM EMERGING ECONOMIES TO SPUR MARKET GROWTH 111
7.10 VIALS 112
7.10.1 DEMAND FOR VACCINE PACKAGING TO DRIVE MARKET 112
7.11 MEDICATION TUBES 112
7.11.1 GROWTH OF FLEXIBLE PACKAGING IN EMERGING ECONOMIES TO BOOST MARKET 112
7.11.2 COMPOSITE TUBES 113
7.11.3 ALL-PLASTIC TUBES 113
7.11.4 COLLAPSIBLE METAL TUBES 113
7.12 JARS & CANISTERS 113
7.12.1 INCREASING DEMAND FOR PROTECTIVE PACKAGING TO FUEL MARKET 113
7.13 CARTRIDGES 113
7.13.1 BALANCED PACKAGING OFFERED BY CARTRIDGES TO DRIVE MARKET 113
7.14 OTHER TYPES 114
8 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE 115
8.1 INTRODUCTION 116
FIGURE 26 PRIMARY PACKAGING FORMAT TO BE LARGER SEGMENT 116
TABLE 42 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2016–2019 (USD MILLION) 116
TABLE 43 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2027 (USD MILLION) 116
8.2 PRIMARY PACKAGING 117
8.2.1 USE OF ALUMINUM OR GLASS TO REDUCE ENVIRONMENTAL IMPACT OF PRIMARY PACKAGING 117
TABLE 44 PRIMARY PACKAGING: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 117
TABLE 45 PRIMARY PACKAGING: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 118
8.3 SECONDARY PACKAGING 118
8.3.1 USE OF PLANT-BASED MATERIALS IN SECONDARY PACKAGING TO GAIN MOMENTUM 118
TABLE 46 SECONDARY PACKAGING: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 119
TABLE 47 SECONDARY PACKAGING: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 119
9 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS 120
9.1 INTRODUCTION 121
FIGURE 27 RECYCLABLE PROCESS SEGMENT TO BE LARGER SEGMENT 121
TABLE 48 PROCESS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 122
TABLE 49 PROCESS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 122
TABLE 50 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 122
TABLE 51 SUSTAINABLE PLASTIC PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 123
9.2 RECYCLABLE 123
9.2.1 FOCUS OF PACKAGING COMPANIES TO IMPROVE RECYCLING INFRASTRUCTURE TO DRIVE MARKET 123
TABLE 52 RECYCLABLE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 124
TABLE 53 RECYCLABLE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 124
9.3 REUSABLE 124
9.3.1 DURABILITY OF TERTIARY PACKAGING TO FUEL MARKET 124
TABLE 54 REUSABLE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 125
TABLE 55 REUSABLE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 125
9.4 BIODEGRADABLE 125
9.4.1 INNOVATION TO PLAY KEY ROLE IN BIODEGRADABLE PLASTIC PACKAGING 125
TABLE 56 BIODEGRADABLE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 126
10 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION 127
10.1 INTRODUCTION 128
FIGURE 28 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET IN INDIA TO REGISTER HIGHEST CAGR 128
TABLE 57 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 129
TABLE 58 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 129
10.2 NORTH AMERICA 129
10.2.1 RECESSION IMPACT 130
FIGURE 29 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SNAPSHOT 131
TABLE 59 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 132
TABLE 60 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 132
TABLE 61 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2016–2019 (USD MILLION) 132
TABLE 62 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2027 (USD MILLION) 132
TABLE 63 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 133
TABLE 64 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 133
TABLE 65 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (USD MILLION) 133
TABLE 66 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (USD MILLION) 134
TABLE 67 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (KILOTON) 134
TABLE 68 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (KILOTON) 134
10.2.2 US 135
10.2.2.1 Environmental responsibility to drive market 135
TABLE 69 US: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 135
TABLE 70 US: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 136
10.2.3 CANADA 136
10.2.3.1 Government initiative to reduce overall quantity of packaging waste to boost market 136
TABLE 71 CANADA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 137
TABLE 72 CANADA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 137
10.2.4 MEXICO 137
10.2.4.1 Gradual economic recovery to support market 137
TABLE 73 MEXICO: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 138
TABLE 74 MEXICO: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 138
10.3 ASIA PACIFIC 138
10.3.1 RECESSION IMPACT 139
FIGURE 30 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SNAPSHOT 140
TABLE 75 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 141
TABLE 76 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 141
TABLE 77 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2016–2019 (USD MILLION) 141
TABLE 78 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2027 (USD MILLION) 142
TABLE 79 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 142
TABLE 80 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 142
TABLE 81 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (USD MILLION) 143
TABLE 82 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (USD MILLION) 143
TABLE 83 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (KILOTON) 143
TABLE 84 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (KILOTON) 144
10.3.2 CHINA 144
10.3.2.1 Increasing awareness of eco-friendly, sustainable, and renewable packaging to drive market 144
TABLE 85 CHINA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 145
TABLE 86 CHINA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 145
10.3.3 JAPAN 146
10.3.3.1 Increasing demand for generic drugs to propel market 146
TABLE 87 JAPAN: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 147
TABLE 88 JAPAN: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 147
10.3.4 SOUTH KOREA 147
10.3.4.1 Well-developed healthcare industry and presence of major pharmaceutical manufacturers to drive market 147
TABLE 89 SOUTH KOREA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 148
TABLE 90 SOUTH KOREA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 148
10.3.5 INDIA 149
10.3.5.1 Increasing domestic consumption and export of generic drugs to fuel market 149
TABLE 91 INDIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 149
TABLE 92 INDIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 150
10.3.6 AUSTRALIA 150
10.3.6.1 PBS schemes to strengthen pharmaceutical industry 150
TABLE 93 AUSTRALIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 151
TABLE 94 AUSTRALIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 151
10.3.7 REST OF ASIA PACIFIC 151
TABLE 95 REST OF ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 152
TABLE 96 REST OF ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 152
10.4 EUROPE 152
10.4.1 RECESSION IMPACT 153
TABLE 97 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 153
TABLE 98 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 153
TABLE 99 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2016–2019 (USD MILLION) 154
TABLE 100 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2027 (USD MILLION) 154
TABLE 101 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 154
TABLE 102 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 154
TABLE 103 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (USD MILLION) 155
TABLE 104 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (USD MILLION) 155
TABLE 105 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (KILOTON) 155
TABLE 106 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (KILOTON) 156
10.4.2 GERMANY 156
10.4.2.1 Government initiatives for boosting recycling rate to drive market 156
TABLE 107 GERMANY: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 157
TABLE 108 GERMANY: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 157
10.4.3 FRANCE 157
10.4.3.1 High demand for generic drugs to drive market 157
TABLE 109 FRANCE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 158
TABLE 110 FRANCE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 158
10.4.4 ITALY 158
10.4.4.1 Growing exports of pharmaceuticals to boost market 158
TABLE 111 ITALY: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 159
TABLE 112 ITALY: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 159
10.4.5 UK 159
10.4.5.1 Innovations in drug manufacturing to increase demand 159
TABLE 113 UK: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 160
TABLE 114 UK: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 160
10.4.6 SPAIN 160
10.4.6.1 Macroeconomic factors to have positive impact on market 160
TABLE 115 SPAIN: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 161
TABLE 116 SPAIN: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 161
10.4.7 RUSSIA 161
10.4.7.1 Government initiatives for domestic production of pharmaceuticals to fuel market 161
TABLE 117 RUSSIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 162
TABLE 118 RUSSIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 162
10.4.8 REST OF EUROPE 162
TABLE 119 REST OF EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 163
TABLE 120 REST OF EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 163
10.5 MIDDLE EAST & AFRICA 163
10.5.1 RECESSION IMPACT 164
TABLE 121 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 164
TABLE 122 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 165
TABLE 123 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2016–2019 (USD MILLION) 165
TABLE 124 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2027 (USD MILLION) 165
TABLE 125 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 165
TABLE 126 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 166
TABLE 127 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (USD MILLION) 166
TABLE 128 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (USD MILLION) 166
TABLE 129 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (KILOTON) 167
TABLE 130 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (KILOTON) 167
10.5.2 SAUDI ARABIA 167
10.5.2.1 Wider access to healthcare services to increase demand for pharmaceuticals 167
TABLE 131 SAUDI ARABIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 168
TABLE 132 SAUDI ARABIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 168
10.5.3 SOUTH AFRICA 169
10.5.3.1 Gradual rise in generic drug use to fuel market 169
TABLE 133 SOUTH AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 169
TABLE 134 SOUTH AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 170
10.5.4 UAE 170
10.5.4.1 Increasing initiatives for domestic pharmaceutical production to drive market 170
TABLE 135 UAE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 170
TABLE 136 UAE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 171
10.5.5 REST OF MIDDLE EAST & AFRICA 171
TABLE 137 REST OF MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 171
TABLE 138 REST OF MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 172
10.6 SOUTH AMERICA 172
10.6.1 RECESSION IMPACT 173
TABLE 139 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 173
TABLE 140 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 173
TABLE 141 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2016–2019 (USD MILLION) 173
TABLE 142 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2027 (USD MILLION) 174
TABLE 143 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 174
TABLE 144 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 174
TABLE 145 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (USD MILLION) 175
TABLE 146 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (USD MILLION) 175
TABLE 147 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (KILOTON) 175
TABLE 148 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (KILOTON) 176
10.6.2 BRAZIL 176
10.6.2.1 Free and universal healthcare services to support pharmaceutical industry 176
TABLE 149 BRAZIL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 177
TABLE 150 BRAZIL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 177
10.6.3 ARGENTINA 177
10.6.3.1 Increasing awareness and development of recycling facilities to drive market 177
TABLE 151 ARGENTINA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 178
TABLE 152 ARGENTINA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 178
10.6.4 REST OF SOUTH AMERICA 178
TABLE 153 REST OF SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 179
TABLE 154 REST OF SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 179
11 COMPETITIVE LANDSCAPE 180
11.1 OVERVIEW 180
11.2 STRATEGIES ADOPTED BY KEY PLAYERS 180
TABLE 155 COMPANIES ADOPTED INVESTMENT & EXPANSION AND PRODUCT LAUNCH AS KEY GROWTH STRATEGIES BETWEEN 2019 AND 2022 180
11.3 MARKET EVALUATION MATRIX 182
TABLE 156 MARKET EVALUATION MATRIX 183
11.4 REVENUE ANALYSIS 183
TABLE 157 REVENUE OF KEY COMPANIES DURING 2019–2021 183
11.5 RANKING ANALYSIS OF KEY MARKET PLAYERS, 2021 184
FIGURE 31 RANKING OF TOP 5 PLAYERS IN SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, 2021 184
11.5.1 BERRY GLOBAL INC. 184
11.5.2 AMCOR PLC 184
11.5.3 APTARGROUP, INC. 184
11.5.4 GERRESHEIMER AG 185
11.5.5 SCHOTT AG 185
11.6 MARKET SHARE ANALYSIS 185
FIGURE 32 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SHARE, BY COMPANY (2021) 185
TABLE 158 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: DEGREE OF COMPETITION 186
11.7 COMPANY EVALUATION MATRIX (TIER-1 PLAYERS) 186
11.7.1 STARS 186
11.7.2 PERVASIVE PLAYERS 186
11.7.3 EMERGING LEADERS 186
11.7.4 PARTICIPANTS 186
FIGURE 33 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX FOR TIER-1 COMPANIES, 2021 187
11.8 STRENGTH OF PRODUCT PORTFOLIO (TIER-1 PLAYERS) 188
11.9 BUSINESS STRATEGY EXCELLENCE (TIER-1 PLAYERS) 188
11.10 START-UP AND SME MATRIX 189
11.10.1 PROGRESSIVE COMPANIES 189
11.10.2 RESPONSIVE COMPANIES 189
11.10.3 STARTING BLOCKS 189
11.10.4 DYNAMIC COMPANIES 189
FIGURE 34 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS AND SMES, 2021 190
11.11 STRENGTH OF PRODUCT PORTFOLIO (START-UPS AND SMES) 191
11.12 BUSINESS STRATEGY EXCELLENCE (START-UPS AND SMES) 191
11.13 COMPETITIVE BENCHMARKING 192
TABLE 159 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: LIST OF COMPANIES 192
11.13.1 COMPANY TYPE FOOTPRINT 193
TABLE 160 OVERALL TYPE FOOTPRINT 193
11.13.2 COMPANY REGION FOOTPRINT 195
TABLE 161 OVERALL REGION FOOTPRINT 195
11.13.3 COMPANY FOOTPRINT 196
TABLE 162 OVERALL COMPANY FOOTPRINT 196
11.14 COMPETITIVE SITUATION AND TRENDS 197
11.14.1 PRODUCT LAUNCHES 197
TABLE 163 PHARMACEUTICAL PACKAGING MARKET: PRODUCT LAUNCHES, 2019–2022 197
11.14.2 DEALS 202
TABLE 164 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: DEALS, 2019–2022 202
11.14.3 OTHER DEVELOPMENTS 209
TABLE 165 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: OTHER DEVELOPMENTS, 2019–2021 209

　

ページTOPに戻る


　

Summary

The global Sustainable pharmaceutical packaging market size is projected to grow from USD 71.6 Billion in 2022 to USD 146.3 Billion by 2027, at a CAGR of 15.4% from 2022 to 2027.
Sustainable pharmaceutical packaging is an important aspect of the healthcare industry, as it protects the integrity of the medication and aims to reduce the environmental impact of packaging materials. With an increasing focus on reducing waste and preserving natural resources, pharmaceutical companies are exploring new and innovative ways to create functional and eco-friendly packaging. This includes using recyclable materials, designing for easy recycling, and implementing packaging reduction strategies

“Glass accounted for the third largest share amongst other raw material in the pharmaceutical packaging market.”
Glass is an amorphous and crystalline material with excellent transparency and chemical inertness. It is mainly used in the primary packaging of pharmaceutical drugs. Various types of primary packaging, such as vials, ampoules, bottles, containers, and syringes, are made from glass. Glass is a permanent material that is infinitely recyclable and reusable, reducing waste and saving natural resources. This means that glass has the potential to be recycled over and over again without any loss of its intrinsic properties. Permanent materials are perfect for maintaining a truly circular material loop. Due to the strength of their chemical bonds, permanent materials are not damaged by the recycling process and can stay in the recycling loop as long as they are properly collected, treated, and re-melted.

“secondary packaging to be the second largest pacakging type in molded fiber pulp packaging during the forecast period.”

Secondary packaging in sustainable pharmaceutical packaging refers to the outer packaging that encloses the primary packaging, which contains the actual medication. It protects the primary packaging and provides information about the product, such as the dosage, expiration date, and manufacturer. Secondary packaging is also known as retail-ready packaging (RRP), shelf-ready packaging (SRP), or counter-top display units (CDUs). The packaging makes it easier for retailers to display and handle products. Using sustainable materials in secondary packaging is becoming increasingly important in the pharmaceutical industry as companies aim to reduce their environmental impact.

“Recyclable process accounted for the largest share of sustainable pharmaceutical packaging during the forecast period.”

The use of recyclable plastics in the sustainable pharmaceutical packaging industry is becoming increasingly important as companies and consumers become more aware of the impact of packaging materials. Recyclable plastics, such as PET and HDPE, can be used to create packaging that is not only environmentally friendly but also cost-effective and safe for the storage and transportation of pharmaceutical products. One of the main benefits of using recyclable plastics in pharmaceutical packaging is that it reduces the amount of waste that ends up in landfills. These materials can be easily collected, sorted, and recycled, which helps conserve natural resources and reduce the industry's carbon footprint. Additionally, recyclable plastics are often lightweight, making them more cost-effective to transport and store. They also have good barrier properties that protect products from moisture, light, and other environmental factors




“Europe is to be the second largest market for sustainable pharmaceutical packaging”
The high demand for pharmaceutical packaging in the region can be attributed to the increasing research, production, and distribution of pharmaceuticals. Significant advancements in the field of medical biopharmaceuticals are further boosting the market in the region. At present, consumers, manufacturers, retailers, advocacy groups, and governments across the region are encouraging environmentally friendly packaging thus contributing to the consistent growth of the sustainable pharmaceutical packaging industry in countries such as Germany, France, and the UK, owing to their environmentally-conscious consumers. All these factors are expected to fuel the demand for sustainable pharmaceutical packaging in the Europe region.

This study has been validated through primaries conducted with various industry experts worldwide. These primary sources have been divided into 3 categories, namely by company, by designation, and by region.
• By Department- Sales/Export/Marketing – 53.5%, Production– 23.3%, CXOs – 23.3%
• By Designation- Managers– 60.5%, CXOs– 23.3%, Executives– 16.3%
• By Region- North America- 33%, Europe- 27%, Asia Pacific- 25%, South America – 5%, and Middle East & Africa - 10%
The key players in the sustaianble pharmaceutical packaging market include Schott AG (Germany), Amcor PLC (Switzerland), AptarGroup,Inc (US), West Pharmaceutical Services, Inc. (US), Berry Global (US), Gerresheimer AG (Germany), Catalent,Inc (US), and WestRock (US).. The study includes an in-depth competitive analysis of these key players in the sustainable pharmaceutical packaging market, with their company profiles, and key market strategies.

Research Coverage
This report provides detailed segmentation of the sustainable pharmaceutical packaging market and forecasts its market size until 2027. The market has been segmented based on raw material, product type, packaging type, process and region. The report also provides detailed information on company profiles and competitive strategies adopted by the key players to strengthen their positions in the market. The report also provides insights into the driving and restraining factors in the sustainable pharmaceutical packaging market, along with opportunities and challenges across these industries. It also includes profiles for top manufacturers in the market.
Reasons to Buy the Report
From an insight perspective, this research report focuses on various levels of analyses — industry analysis (industry trends), market ranking of top players, and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the sustainable pharmaceutical packaging market; high growth regions; and market drivers, restraints, opportunities, and challenges



ページTOPに戻る


Table of Contents

1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.3 STUDY SCOPE 35
1.3.1 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SEGMENTATION 35
1.3.2 REGIONAL SCOPE 35
1.4 YEARS CONSIDERED 36
1.5 CURRENCY CONSIDERED 36
1.6 UNIT CONSIDERED 36
1.7 STAKEHOLDERS 36
1.8 INCLUSIONS AND EXCLUSIONS 37
TABLE 1 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: INCLUSIONS AND EXCLUSIONS 37
1.9 SUMMARY OF CHANGES 37
1.10 LIMITATIONS 38
2 RESEARCH METHODOLOGY 39
2.1 RESEARCH DATA 39
FIGURE 1 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: RESEARCH DESIGN 39
2.1.1 SECONDARY DATA 40
2.1.1.1 Key data from secondary sources 40
2.1.2 PRIMARY DATA 40
2.1.2.1 Key data from primary sources 41
2.1.2.2 Key primary insights 42
FIGURE 2 LIST OF STAKEHOLDERS AND BREAKDOWN OF PRIMARY INTERVIEWS 42
2.2 MARKET SIZE ESTIMATION 43
FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 43
FIGURE 4 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 43
FIGURE 5 MARKET SIZE ESTIMATION: SUPPLY SIDE 44
2.3 DATA TRIANGULATION 45
FIGURE 6 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: DATA TRIANGULATION 45
2.4 RESEARCH ASSUMPTIONS 46
2.5 RESEARCH LIMITATIONS 46
2.6 GROWTH FORECAST 46
3 EXECUTIVE SUMMARY 47
FIGURE 7 PLASTICS TO HOLD LARGEST SHARE IN SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET 47
FIGURE 8 PRIMARY PACKAGING TO BE FASTER-GROWING SEGMENT OF SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET 48
FIGURE 9 BIODEGRADABLE SEGMENT TO GROW AT HIGHEST CAGR FROM 2022 TO 2027 48
FIGURE 10 ASIA PACIFIC TO BE FASTEST-GROWING PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD 49
4 PREMIUM INSIGHTS 50
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET 50
FIGURE 11 EMERGING ECONOMIES TO OFFER ATTRACTIVE OPPORTUNITIES IN SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET 50
4.2 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL 50
FIGURE 12 PLASTICS SEGMENT TO REGISTER HIGHEST CAGR FROM 2022 TO 2027 50
4.3 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION AND RAW MATERIAL, 2021 51
FIGURE 13 NORTH AMERICA AND PLASTICS SEGMENT ACCOUNTED FOR LARGEST SHARES 51
4.4 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY KEY COUNTRIES 52
FIGURE 14 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET IN INDIA TO WITNESS HIGHEST CAGR 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 54
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET 54
5.2.1 DRIVERS 54
5.2.1.1 Government initiatives for sustainable packaging 54
5.2.1.2 Consumer preference toward recyclable and eco-friendly materials 55
5.2.1.3 Downsizing of packaging 56
5.2.1.4 Breakthrough in new technologies and innovations 56
5.2.1.5 High growth in generics and biopharmaceuticals markets 57
5.2.2 RESTRAINTS 57
5.2.2.1 Poor infrastructure facilities for recycling 57
5.2.2.2 Lack of awareness of sustainability 57
5.2.2.3 High packaging costs 58
5.2.3 OPPORTUNITIES 59
5.2.3.1 Growing demand for primary pharmaceutical packaging 59
5.2.4 CHALLENGES 59
5.2.4.1 Volatile raw material prices 59
5.3 VALUE CHAIN ANALYSIS 60
FIGURE 16 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: VALUE CHAIN ANALYSIS 60
5.3.1 RAW MATERIAL SUPPLIERS 60
5.3.2 R&D OF PRODUCTS 60
5.3.3 MANUFACTURERS 61
5.3.4 DISTRIBUTORS 61
5.3.5 END USERS 61
5.3.6 POST-DISPOSAL PROCESS 62
TABLE 2 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKETING: VALUE CHAIN STAKEHOLDERS 63
5.4 PORTER'S FIVE FORCES ANALYSIS 64
FIGURE 17 PORTER'S FIVE FORCES ANALYSIS OF SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET 64
5.4.1 THREAT OF NEW ENTRANTS 64
5.4.2 THREAT OF SUBSTITUTES 65
5.4.3 BARGAINING POWER OF BUYERS 65
5.4.4 BARGAINING POWER OF SUPPLIERS 66
5.4.5 INTENSITY OF COMPETITIVE RIVALRY 66
TABLE 3 IMPACT OF PORTER'S FIVE FORCES ON SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET 66
5.5 REGULATORY LANDSCAPE 67
5.5.1 REGULATIONS 67
5.5.1.1 Europe 67
5.5.1.2 US 67
5.5.1.3 Others 68
5.6 TECHNOLOGY ANALYSIS 68
5.6.1 AUTOMATED RECYCLING 68
5.6.2 EMERGENCE OF TECHNOLOGICALLY ADVANCED RAW MATERIALS 68
5.6.3 NANOTECHNOLOGY 69
5.6.4 PACKAGING FOR BIOLOGICS 69
5.6.5 SMART PACKAGING 69
5.6.6 ANTI-COUNTERFEIT PACKAGING 70
5.6.7 OTHER SMART TRENDS AND TECHNOLOGIES 70
5.7 PRICING ANALYSIS 71
5.7.1 AVERAGE SELLING PRICE, BY REGION 71
FIGURE 18 AVERAGE SELLING PRICE, BY REGION (USD/KG) 71
5.7.2 AVERAGE SELLING PRICE, BY RAW MATERIAL 71
TABLE 4 AVERAGE SELLING PRICE, BY RAW MATERIAL (USD/KG) 71
5.7.3 AVERAGE SELLING PRICE, BY COMPANY 72
TABLE 5 AVERAGE SELLING PRICE, BY COMPANY (USD/KG) 72
5.8 ECOSYSTEM MAPPING 72
FIGURE 19 PHARMACEUTICAL PACKAGING MARKET: ECOSYSTEM MAPPING 72
5.9 IMPACT OF COVID-19 ON PHARMACEUTICAL PACKAGING MARKET 73
5.9.1 IMPACT ON HEALTHCARE INDUSTRY 73
5.10 IMPACT OF RECESSION ON PHARMACEUTICAL PACKAGING MARKET 74
5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 75
FIGURE 20 SMART PACKAGING, IOT, AND NANOTECHNOLOGY TO DRIVE MARKET 75
5.12 PATENT ANALYSIS 75
5.12.1 INTRODUCTION 75
5.12.2 METHODOLOGY 75
5.12.3 DOCUMENT TYPE 76
FIGURE 21 GRANTED PATENTS, LIMITED PATENTS, AND PATENT APPLICATIONS 76
5.12.4 PUBLICATION TRENDS DURING 2011–2021 76
FIGURE 22 NUMBER OF PATENTS DURING 2011–2021 76
5.12.5 INSIGHTS 77
5.12.6 JURISDICTION ANALYSIS 77
FIGURE 23 TOP JURISDICTIONS 77
5.12.7 TOP PATENT APPLICANTS 77
FIGURE 24 TOP 10 PATENT APPLICANTS 78
TABLE 6 LIST OF PATENTS BY SANOFI AVENTIS DEUTSCHLAND 78
TABLE 7 LIST OF PATENTS BY SCHOTT AG 79
TABLE 8 LIST OF PATENTS BY TERUMO CORP 79
TABLE 9 LIST OF PATENTS BY BECTON, DICKINSON AND COMPANY 80
TABLE 10 TOP 10 PATENT OWNERS (US) IN LAST 10 YEARS 81
5.13 TRADE ANALYSIS 81
5.14 OPERATIONAL DATA 82
5.15 KEY CONFERENCES AND EVENTS IN 2022–2023 83
TABLE 11 KEY CONFERENCES AND EVENTS IN 2022–2023 83
5.16 CASE STUDY ANALYSIS 84
5.16.1 OPTHALMIC SQUEEZE DISPENSER BY APTAR PHARMA TO CONTRIBUTE TO OVERALL ESG COMMITMENTS 84
5.16.2 MOISTURE BARRIER TECHNOLOGY FOR BETTER DRUG DELIVERY 84
5.16.3 CUSTOM TECHNOLOGY FOR BETTER BREATHING 85
6 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL 86
6.1 INTRODUCTION 87
FIGURE 25 PLASTICS TO DOMINATE SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET 87
TABLE 12 BASIC PACKAGING RAW MATERIALS USED IN PHARMACEUTICAL PACKAGING 87
TABLE 13 RAW MATERIAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 88
TABLE 14 RAW MATERIAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 89
TABLE 15 RAW MATERIAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (KILOTON) 89
TABLE 16 RAW MATERIAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (KILOTON) 89
TABLE 17 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (USD MILLION) 90
TABLE 18 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (USD MILLION) 90
TABLE 19 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (KILOTON) 90
TABLE 20 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (KILOTON) 91
6.2 PLASTICS 91
6.2.1 COST-EFFECTIVENESS AND EXCELLENT BARRIER PROPERTIES OF PLASTICS TO DRIVE MARKET 91
TABLE 21 PLASTICS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 92
TABLE 22 PLASTICS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 92
TABLE 23 PLASTICS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (KILOTON) 92
TABLE 24 PLASTICS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (KILOTON) 93
6.2.2 HIGH-DENSITY POLYETHYLENE (HDPE) 93
6.2.3 POLYPROPYLENE (PP) 93
6.2.4 LOW-DENSITY POLYETHYLENE (LDPE) 94
6.2.5 POLYVINYL CHLORIDE (PVC) 94
6.2.6 POLYETHYLENE TEREPHTHALATE (PET) 94
6.2.7 BIO-BASED PLASTICS (BBP) 94
6.2.8 BIODEGRADABLE PLASTICS 95
6.3 PAPER & PAPERBOARD 95
6.3.1 INNOVATIONS IN SECONDARY PACKAGING TO BOOST MARKET 95
TABLE 25 PAPER & PAPERBOARD: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 96
TABLE 26 PAPER & PAPERBOARD: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 96
TABLE 27 PAPER & PAPERBOARD: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (KILOTON) 96
TABLE 28 PAPER & PAPERBOARD: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (KILOTON) 97
6.4 GLASS 97
6.4.1 EXCELLENT CHEMICAL RESISTANCE AND RECYCLABILITY OF GLASS TO PROPEL MARKET 97
TABLE 29 GLASS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 98
TABLE 30 GLASS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 98
TABLE 31 GLASS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (KILOTON) 98
TABLE 32 GLASS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (KILOTON) 99
TABLE 33 TYPES OF GLASS USED IN PACKAGING 100
6.5 METAL 100
6.5.1 INCREASING USE OF ALUMINUM FOR BLISTER PACKAGING TO DRIVE MARKET 100
TABLE 34 METAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 101
TABLE 35 METAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 101
TABLE 36 METAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (KILOTON) 102
TABLE 37 METAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (KILOTON) 102
6.6 OTHER RAW MATERIALS 103
TABLE 38 OTHER RAW MATERIALS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 104
TABLE 39 OTHER RAW MATERIALS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 104
TABLE 40 OTHER RAW MATERIALS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (KILOTON) 104
TABLE 41 OTHER RAW MATERIALS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (KILOTON) 105
7 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PRODUCT TYPE 106
7.1 INTRODUCTION 106
7.2 PLASTIC BOTTLES 106
7.2.1 EASY OPERABILITY AND SHATTER RESISTANCE OF PLASTIC BOTTLES TO SUPPORT MARKET 106
7.2.2 STANDARD PLASTIC BOTTLES 107
7.2.3 PLASTIC DISPENSING BOTTLES 107
7.2.4 PLASTIC JARS 107
7.3 LABELS & ACCESSORIES 107
7.3.1 PATIENT-DRUG COMMUNICATION COMPLIANCE TO DRIVE MARKET 107
7.3.2 SELF-ADHESIVE LABELS 108
7.3.3 DIE-CUT LABELS 108
7.3.4 TAMPER-PROOF LABELS 108
7.3.5 HOLOGRAPHIC STRIP LABELS 108
7.4 CAPS & CLOSURES 109
7.4.1 PREFERENCE FOR POLYPROPYLENE AND POLYETHYLENE-BASED CAPS & CLOSURES TO FAVOR MARKET GROWTH 109
7.5 MEDICAL SPECIALTY BAGS 109
7.5.1 WIDE USE OF LLDPE AND PE TO CONTRIBUTE TO MARKET GROWTH 109
7.6 PREFILLED SYRINGES 110
7.6.1 HIGH DEMAND IN DEVELOPED AND EMERGING ECONOMIES TO DRIVE MARKET 110
7.7 TEMPERATURE-CONTROLLED PACKAGING 110
7.7.1 INCREASING PRODUCTION OF SPECIALIZED DRUGS TO INFLUENCE MARKET GROWTH POSITIVELY 110
7.8 POUCHES & STRIP PACKS 111
7.8.1 GROWING DEMAND FOR STANDUP POUCHES TO DRIVE MARKET 111
7.9 AMPOULES 111
7.9.1 HIGH DEMAND FROM EMERGING ECONOMIES TO SPUR MARKET GROWTH 111
7.10 VIALS 112
7.10.1 DEMAND FOR VACCINE PACKAGING TO DRIVE MARKET 112
7.11 MEDICATION TUBES 112
7.11.1 GROWTH OF FLEXIBLE PACKAGING IN EMERGING ECONOMIES TO BOOST MARKET 112
7.11.2 COMPOSITE TUBES 113
7.11.3 ALL-PLASTIC TUBES 113
7.11.4 COLLAPSIBLE METAL TUBES 113
7.12 JARS & CANISTERS 113
7.12.1 INCREASING DEMAND FOR PROTECTIVE PACKAGING TO FUEL MARKET 113
7.13 CARTRIDGES 113
7.13.1 BALANCED PACKAGING OFFERED BY CARTRIDGES TO DRIVE MARKET 113
7.14 OTHER TYPES 114
8 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE 115
8.1 INTRODUCTION 116
FIGURE 26 PRIMARY PACKAGING FORMAT TO BE LARGER SEGMENT 116
TABLE 42 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2016–2019 (USD MILLION) 116
TABLE 43 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2027 (USD MILLION) 116
8.2 PRIMARY PACKAGING 117
8.2.1 USE OF ALUMINUM OR GLASS TO REDUCE ENVIRONMENTAL IMPACT OF PRIMARY PACKAGING 117
TABLE 44 PRIMARY PACKAGING: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 117
TABLE 45 PRIMARY PACKAGING: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 118
8.3 SECONDARY PACKAGING 118
8.3.1 USE OF PLANT-BASED MATERIALS IN SECONDARY PACKAGING TO GAIN MOMENTUM 118
TABLE 46 SECONDARY PACKAGING: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 119
TABLE 47 SECONDARY PACKAGING: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 119
9 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS 120
9.1 INTRODUCTION 121
FIGURE 27 RECYCLABLE PROCESS SEGMENT TO BE LARGER SEGMENT 121
TABLE 48 PROCESS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 122
TABLE 49 PROCESS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 122
TABLE 50 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 122
TABLE 51 SUSTAINABLE PLASTIC PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 123
9.2 RECYCLABLE 123
9.2.1 FOCUS OF PACKAGING COMPANIES TO IMPROVE RECYCLING INFRASTRUCTURE TO DRIVE MARKET 123
TABLE 52 RECYCLABLE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 124
TABLE 53 RECYCLABLE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 124
9.3 REUSABLE 124
9.3.1 DURABILITY OF TERTIARY PACKAGING TO FUEL MARKET 124
TABLE 54 REUSABLE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 125
TABLE 55 REUSABLE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 125
9.4 BIODEGRADABLE 125
9.4.1 INNOVATION TO PLAY KEY ROLE IN BIODEGRADABLE PLASTIC PACKAGING 125
TABLE 56 BIODEGRADABLE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 126
10 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION 127
10.1 INTRODUCTION 128
FIGURE 28 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET IN INDIA TO REGISTER HIGHEST CAGR 128
TABLE 57 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 129
TABLE 58 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 129
10.2 NORTH AMERICA 129
10.2.1 RECESSION IMPACT 130
FIGURE 29 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SNAPSHOT 131
TABLE 59 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 132
TABLE 60 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 132
TABLE 61 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2016–2019 (USD MILLION) 132
TABLE 62 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2027 (USD MILLION) 132
TABLE 63 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 133
TABLE 64 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 133
TABLE 65 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (USD MILLION) 133
TABLE 66 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (USD MILLION) 134
TABLE 67 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (KILOTON) 134
TABLE 68 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (KILOTON) 134
10.2.2 US 135
10.2.2.1 Environmental responsibility to drive market 135
TABLE 69 US: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 135
TABLE 70 US: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 136
10.2.3 CANADA 136
10.2.3.1 Government initiative to reduce overall quantity of packaging waste to boost market 136
TABLE 71 CANADA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 137
TABLE 72 CANADA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 137
10.2.4 MEXICO 137
10.2.4.1 Gradual economic recovery to support market 137
TABLE 73 MEXICO: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 138
TABLE 74 MEXICO: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 138
10.3 ASIA PACIFIC 138
10.3.1 RECESSION IMPACT 139
FIGURE 30 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SNAPSHOT 140
TABLE 75 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 141
TABLE 76 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 141
TABLE 77 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2016–2019 (USD MILLION) 141
TABLE 78 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2027 (USD MILLION) 142
TABLE 79 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 142
TABLE 80 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 142
TABLE 81 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (USD MILLION) 143
TABLE 82 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (USD MILLION) 143
TABLE 83 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (KILOTON) 143
TABLE 84 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (KILOTON) 144
10.3.2 CHINA 144
10.3.2.1 Increasing awareness of eco-friendly, sustainable, and renewable packaging to drive market 144
TABLE 85 CHINA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 145
TABLE 86 CHINA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 145
10.3.3 JAPAN 146
10.3.3.1 Increasing demand for generic drugs to propel market 146
TABLE 87 JAPAN: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 147
TABLE 88 JAPAN: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 147
10.3.4 SOUTH KOREA 147
10.3.4.1 Well-developed healthcare industry and presence of major pharmaceutical manufacturers to drive market 147
TABLE 89 SOUTH KOREA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 148
TABLE 90 SOUTH KOREA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 148
10.3.5 INDIA 149
10.3.5.1 Increasing domestic consumption and export of generic drugs to fuel market 149
TABLE 91 INDIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 149
TABLE 92 INDIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 150
10.3.6 AUSTRALIA 150
10.3.6.1 PBS schemes to strengthen pharmaceutical industry 150
TABLE 93 AUSTRALIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 151
TABLE 94 AUSTRALIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 151
10.3.7 REST OF ASIA PACIFIC 151
TABLE 95 REST OF ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 152
TABLE 96 REST OF ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 152
10.4 EUROPE 152
10.4.1 RECESSION IMPACT 153
TABLE 97 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 153
TABLE 98 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 153
TABLE 99 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2016–2019 (USD MILLION) 154
TABLE 100 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2027 (USD MILLION) 154
TABLE 101 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 154
TABLE 102 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 154
TABLE 103 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (USD MILLION) 155
TABLE 104 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (USD MILLION) 155
TABLE 105 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (KILOTON) 155
TABLE 106 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (KILOTON) 156
10.4.2 GERMANY 156
10.4.2.1 Government initiatives for boosting recycling rate to drive market 156
TABLE 107 GERMANY: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 157
TABLE 108 GERMANY: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 157
10.4.3 FRANCE 157
10.4.3.1 High demand for generic drugs to drive market 157
TABLE 109 FRANCE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 158
TABLE 110 FRANCE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 158
10.4.4 ITALY 158
10.4.4.1 Growing exports of pharmaceuticals to boost market 158
TABLE 111 ITALY: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 159
TABLE 112 ITALY: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 159
10.4.5 UK 159
10.4.5.1 Innovations in drug manufacturing to increase demand 159
TABLE 113 UK: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 160
TABLE 114 UK: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 160
10.4.6 SPAIN 160
10.4.6.1 Macroeconomic factors to have positive impact on market 160
TABLE 115 SPAIN: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 161
TABLE 116 SPAIN: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 161
10.4.7 RUSSIA 161
10.4.7.1 Government initiatives for domestic production of pharmaceuticals to fuel market 161
TABLE 117 RUSSIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 162
TABLE 118 RUSSIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 162
10.4.8 REST OF EUROPE 162
TABLE 119 REST OF EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 163
TABLE 120 REST OF EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 163
10.5 MIDDLE EAST & AFRICA 163
10.5.1 RECESSION IMPACT 164
TABLE 121 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 164
TABLE 122 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 165
TABLE 123 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2016–2019 (USD MILLION) 165
TABLE 124 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2027 (USD MILLION) 165
TABLE 125 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 165
TABLE 126 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 166
TABLE 127 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (USD MILLION) 166
TABLE 128 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (USD MILLION) 166
TABLE 129 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (KILOTON) 167
TABLE 130 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (KILOTON) 167
10.5.2 SAUDI ARABIA 167
10.5.2.1 Wider access to healthcare services to increase demand for pharmaceuticals 167
TABLE 131 SAUDI ARABIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 168
TABLE 132 SAUDI ARABIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 168
10.5.3 SOUTH AFRICA 169
10.5.3.1 Gradual rise in generic drug use to fuel market 169
TABLE 133 SOUTH AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 169
TABLE 134 SOUTH AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 170
10.5.4 UAE 170
10.5.4.1 Increasing initiatives for domestic pharmaceutical production to drive market 170
TABLE 135 UAE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 170
TABLE 136 UAE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 171
10.5.5 REST OF MIDDLE EAST & AFRICA 171
TABLE 137 REST OF MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 171
TABLE 138 REST OF MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 172
10.6 SOUTH AMERICA 172
10.6.1 RECESSION IMPACT 173
TABLE 139 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 173
TABLE 140 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 173
TABLE 141 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2016–2019 (USD MILLION) 173
TABLE 142 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2027 (USD MILLION) 174
TABLE 143 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 174
TABLE 144 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 174
TABLE 145 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (USD MILLION) 175
TABLE 146 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (USD MILLION) 175
TABLE 147 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (KILOTON) 175
TABLE 148 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (KILOTON) 176
10.6.2 BRAZIL 176
10.6.2.1 Free and universal healthcare services to support pharmaceutical industry 176
TABLE 149 BRAZIL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 177
TABLE 150 BRAZIL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 177
10.6.3 ARGENTINA 177
10.6.3.1 Increasing awareness and development of recycling facilities to drive market 177
TABLE 151 ARGENTINA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 178
TABLE 152 ARGENTINA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 178
10.6.4 REST OF SOUTH AMERICA 178
TABLE 153 REST OF SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 179
TABLE 154 REST OF SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 179
11 COMPETITIVE LANDSCAPE 180
11.1 OVERVIEW 180
11.2 STRATEGIES ADOPTED BY KEY PLAYERS 180
TABLE 155 COMPANIES ADOPTED INVESTMENT & EXPANSION AND PRODUCT LAUNCH AS KEY GROWTH STRATEGIES BETWEEN 2019 AND 2022 180
11.3 MARKET EVALUATION MATRIX 182
TABLE 156 MARKET EVALUATION MATRIX 183
11.4 REVENUE ANALYSIS 183
TABLE 157 REVENUE OF KEY COMPANIES DURING 2019–2021 183
11.5 RANKING ANALYSIS OF KEY MARKET PLAYERS, 2021 184
FIGURE 31 RANKING OF TOP 5 PLAYERS IN SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, 2021 184
11.5.1 BERRY GLOBAL INC. 184
11.5.2 AMCOR PLC 184
11.5.3 APTARGROUP, INC. 184
11.5.4 GERRESHEIMER AG 185
11.5.5 SCHOTT AG 185
11.6 MARKET SHARE ANALYSIS 185
FIGURE 32 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SHARE, BY COMPANY (2021) 185
TABLE 158 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: DEGREE OF COMPETITION 186
11.7 COMPANY EVALUATION MATRIX (TIER-1 PLAYERS) 186
11.7.1 STARS 186
11.7.2 PERVASIVE PLAYERS 186
11.7.3 EMERGING LEADERS 186
11.7.4 PARTICIPANTS 186
FIGURE 33 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX FOR TIER-1 COMPANIES, 2021 187
11.8 STRENGTH OF PRODUCT PORTFOLIO (TIER-1 PLAYERS) 188
11.9 BUSINESS STRATEGY EXCELLENCE (TIER-1 PLAYERS) 188
11.10 START-UP AND SME MATRIX 189
11.10.1 PROGRESSIVE COMPANIES 189
11.10.2 RESPONSIVE COMPANIES 189
11.10.3 STARTING BLOCKS 189
11.10.4 DYNAMIC COMPANIES 189
FIGURE 34 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS AND SMES, 2021 190
11.11 STRENGTH OF PRODUCT PORTFOLIO (START-UPS AND SMES) 191
11.12 BUSINESS STRATEGY EXCELLENCE (START-UPS AND SMES) 191
11.13 COMPETITIVE BENCHMARKING 192
TABLE 159 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: LIST OF COMPANIES 192
11.13.1 COMPANY TYPE FOOTPRINT 193
TABLE 160 OVERALL TYPE FOOTPRINT 193
11.13.2 COMPANY REGION FOOTPRINT 195
TABLE 161 OVERALL REGION FOOTPRINT 195
11.13.3 COMPANY FOOTPRINT 196
TABLE 162 OVERALL COMPANY FOOTPRINT 196
11.14 COMPETITIVE SITUATION AND TRENDS 197
11.14.1 PRODUCT LAUNCHES 197
TABLE 163 PHARMACEUTICAL PACKAGING MARKET: PRODUCT LAUNCHES, 2019–2022 197
11.14.2 DEALS 202
TABLE 164 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: DEALS, 2019–2022 202
11.14.3 OTHER DEVELOPMENTS 209
TABLE 165 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: OTHER DEVELOPMENTS, 2019–2021 209

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

MarketsandMarkets社のPackaging分野での最新刊レポート

本レポートと同じKEY WORD（pharmaceutical）の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


MarketsandMarkets社はどのような調査会社ですか?


マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22　10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.